Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on June 9, 2026

Jun. 9, 2026

Flyte Announces World Cup Activation Strategy, Targeting Global Travel Demand Surrounding 2026 Tournament

Indeterminate GlobeNewswire

Jun. 9, 2026

Linnaeus Therapeutics Announces Selection of LNS8801 into the National Institute on Aging Interventions Testing Program

Indeterminate GlobeNewswire

Jun. 9, 2026

Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003) 

Indeterminate GlobeNewswire

Jun. 9, 2026

Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long-Acting Anti-TSLP Antibody WIN378

Indeterminate GlobeNewswire

Jun. 9, 2026

Chiesi Global Rare Diseases Announces Health Canada Grants Priority Review for FILSUVEZ® (birch triterpenes) Topical Gel for the Treatment of Epidermolysis Bullosa

Indeterminate GlobeNewswire

Jun. 9, 2026

R1 Appoints Eric Tagliere as Chief Information Officer

Indeterminate GlobeNewswire

Jun. 9, 2026

Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

Indeterminate GlobeNewswire

Jun. 9, 2026

Vaxart to Participate in BTIG Infectious Disease Day 2026

Indeterminate GlobeNewswire

Jun. 9, 2026

Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update

Indeterminate GlobeNewswire

Jun. 9, 2026

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

Indeterminate GlobeNewswire

Jun. 9, 2026

BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting

Indeterminate GlobeNewswire

Jun. 9, 2026

CVRx Announces Chief Financial Officer Transition

Indeterminate GlobeNewswire

Jun. 9, 2026

Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China

Indeterminate GlobeNewswire

Jun. 9, 2026

TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial

Indeterminate GlobeNewswire

Jun. 9, 2026

Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy

Indeterminate GlobeNewswire

Jun. 9, 2026

Kraig Biocraft Laboratories Sets New All-Time Production Record, Delivering Nearly 2.5 Metric Tons of Recombinant Spider Silk in Single Production Cycle

Indeterminate GlobeNewswire

Jun. 9, 2026

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine…

Indeterminate GlobeNewswire

Jun. 9, 2026

MitoRx Therapeutics Strengthens Leadership Team with C-Suite and Board Appointments to Support Next Phase of Growth

Indeterminate GlobeNewswire

Jun. 9, 2026

DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 9, 2026

DBV Technologies révise sa participation à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs

Indeterminate GlobeNewswire